Eton Pharmaceuticals, Inc. financial data

Symbol
ETON on Nasdaq
Location
Deer Park, IL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 181% % 18%
Quick Ratio 54% % 421%
Debt-to-equity 282% % 144%
Return On Equity -28% % 23%
Return On Assets -7% % 57%
Operating Margin -4% % 75%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26,817,535 shares 3.8%
Common Stock, Shares, Outstanding 26,817,535 shares 3.8%
Entity Public Float $80,200,000 USD -5.3%
Common Stock, Value, Issued $27,000 USD 3.8%
Weighted Average Number of Shares Outstanding, Basic 26,893,000 shares 3.8%
Weighted Average Number of Shares Outstanding, Diluted 26,893,000 shares 1.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $70,316,000 USD 103%
Research and Development Expense $5,114,000 USD -1.1%
General and Administrative Expense $33,681,000 USD 63%
Operating Income (Loss) $2,679,000 USD 49%
Nonoperating Income (Expense) $1,211,000 USD -341%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $6,483,000 USD -22%
Income Tax Expense (Benefit) $199,000 USD 14%
Net Income (Loss) Attributable to Parent $6,682,000 USD -22%
Earnings Per Share, Basic 0 USD/shares -8.7%
Earnings Per Share, Diluted -0.07 USD/shares -450%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $37,121,000 USD 83%
Accounts Receivable, after Allowance for Credit Loss, Current $13,082,000 USD 134%
Inventory, Net $16,855,000 USD 770%
Assets, Current $72,000,000 USD 142%
Property, Plant and Equipment, Net $294,000 USD 791%
Operating Lease, Right-of-Use Asset $319,000 USD 65%
Intangible Assets, Net (Excluding Goodwill) $31,878,000 USD 445%
Other Assets, Noncurrent $19,000 USD 58%
Assets $104,510,000 USD 192%
Accounts Payable, Current $14,259,000 USD 431%
Accrued Liabilities, Current $9,117,000 USD
Liabilities, Current $44,183,000 USD 124%
Operating Lease, Liability, Noncurrent $480,000 USD 281%
Other Liabilities, Noncurrent $3,942,000 USD
Liabilities $81,384,000 USD 310%
Retained Earnings (Accumulated Deficit) $113,977,000 USD -6.2%
Stockholders' Equity Attributable to Parent $23,126,000 USD 45%
Liabilities and Equity $104,510,000 USD 192%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,090,000 USD
Net Cash Provided by (Used in) Financing Activities $394,000 USD
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 26,817,535 shares 3.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,484,000 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $642,000 USD 238%
Deferred Tax Assets, Valuation Allowance $20,589,000 USD -4.3%
Deferred Tax Assets, Gross $20,993,000 USD -3.2%
Operating Lease, Liability $510,000 USD 154%
Depreciation $48,000 USD 6.7%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $725,000 USD 222%
Property, Plant and Equipment, Gross $480,000 USD 6%
Operating Lease, Liability, Current $30,000 USD -60%
Lessee, Operating Lease, Liability, to be Paid, Year Two $127,000 USD 41%
Lessee, Operating Lease, Liability, to be Paid, Year One $22,000 USD -75%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $215,000 USD 796%
Lessee, Operating Lease, Liability, to be Paid, Year Three $135,000 USD 487%
Deferred Tax Assets, Operating Loss Carryforwards $14,145,000 USD -8.4%
Unrecognized Tax Benefits $382,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $139,000 USD
Operating Lease, Payments $23,000 USD 130%
Additional Paid in Capital $137,076,000 USD
Amortization of Intangible Assets $1,877,000 USD 126%
Deferred Tax Assets, Net of Valuation Allowance $404,000 USD 139%
Share-based Payment Arrangement, Expense $1,200,000 USD 46%
Interest Expense $1,212,000 USD 474%